This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Konstam, M. A. Articles by Brockway, B. A. Search for Related Content PubMed PubMed Citation Articles by Konstam, M. A. Articles by Brockway, B. A.

Circulation, Vol 74, 359-366, Copyright © 1986 by American Heart Association

ARTICLES

Effect of amrinone on right ventricular function: predominance of afterload reduction

MA Konstam, SR Cohen, DN Salem, D Das, MJ Aronovitz and BA Brockway

Although the bipyridine agent amrinone is reported to have a positive inotropic effect on the left ventricle, the effect of this drug on right ventricular contractility in the clinical setting is unknown. We studied the effect of short-term intravenous administration of amrinone on right ventricular systolic function in nine patients with severe congestive heart failure and, using radionuclide ventriculography, examined the right ventricular end-systolic pressure-volume relationship to determine whether reduced right ventricular afterload or increased contractility predominantly accounted for the observed improvement in right ventricular systolic function. In each patient the right ventricular end-systolic pressure-volume relationship was derived with use of varying doses of nitroprusside. After nitroprusside was stopped, intravenous amrinone (3 mg/kg) caused decreases from baseline in pulmonary arterial end-systolic pressure in eight of nine patients (23 +/- 11% [overall mean +/- SE], p less than .05), and in pulmonary vascular resistance in all patients (38 +/- 6%, p less than .001). Right ventricular end-systolic volume decreased (23 +/- 8%, p less than .01) and right ventricular ejection fraction increased (31 +/- 10%, p = .01). The amrinone-induced decrease in right ventricular end-systolic volume was compared with that predicted for right ventricular afterload reduction alone based on the effect of amrinone on pulmonary arterial end-systolic pressure and the pressure-volume relationship observed during infusion of nitroprusside.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				Y. Ochiai, S. Morita, Y. Tanoue, Y. Kawachi, R. Tominaga, and H. Yasui Effects of amrinone, a phosphodiesterase inhibitor, on right ventricular/arterial coupling immediately after cardiac operations J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 139 - 147. [Abstract] [Full Text]

				Long-term Results of Mitral Valve Surgery in Patients with Severe Pulmonary Hypertension Ann. Thorac. Surg., May 1, 1996; 61(5): 1583 - 1584. [Full Text]